Bioanalytical assessments provide indispensable tools used throughout the drug development lifecycle. From early discovery through to product release and beyond, they play a crucial role in evaluating a therapeutic’s efficacy, safety and quality. The complexity and requirements of these assays vary widely, tailored to address specific scientific and/or regulatory questions. RoukenBio’s bioanalytical experts design and implement complex assays, create high-throughput methods and can provide off-the-shelf solutions for complex therapeutics.
SPR
Single-Cell Interaction Cytometry
